Murine and human peripheral blood monocytes are heterogeneous in size, granularity, nuclear morphology, phenotype and function. Whether and how bovine blood monocytes follow this pattern was analyzed in this study. Flow cytometrically, classical monocytes (cM) CD14+ CD16−, intermediate monocytes (intM) CD14+ CD16+ and nonclassical monocytes (ncM) CD14+ CD16+ were identified, with cM being the predominant subset (89%). cM showed a significant lower expression of CD172a, intM expressed the highest level of MHC class II molecules, and ncM were low positive for CD163. Compared to cM and intM, ncM showed a significantly reduced phagocytosis capacity, a significantly reduced generation of reactive oxygen species, and reduced mRNA expression of CXCL8, CXCL1 and IL-1β after LPS stimulation. Based on IL-1β secretion after LPS/ATP stimulation, the inflammasome could be activated in cM and intM, but not in ncM. IFNγ increased the expression of CD16 selectively on cM and induced a shift from cM into intM in vitro. In summary, bovine CD172a-positive mononuclear cells define three monocyte subsets with distinct phenotypic and functional differences. Bovine cM and intM share homologies with their human counterparts, whereas bovine ncM are not inflammatory monocytes.
Citation: Hussen J, Düvel A, Sandra O, Smith D, Sheldon IM, Zieger P, et al. (2013) Phenotypic and Functional Heterogeneity of Bovine Blood Monocytes. PLoS ONE 8(8): e71502. https://doi.org/10.1371/journal.pone.0071502
Editor: Gourapura J. Renukaradhya, The Ohio State University, United States of America
Received: April 2, 2013; Accepted: July 1, 2013; Published: August 14, 2013
Copyright: © 2013 Hussen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funded by Bundesministerium für Bildung und Forschung, www.bmbf.de, Grant: FKZ 0315861, Project ‘EMIDA-Era-Net: iPUD- integrierter systemischer Ansatz zur Verhinderung uteriner Erkrankungen beim Rind’. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: PZ (Zoetis, formerly Pfizer Animal Health) is part of a European Union-funded project were a company is involved in the translation of basic science into a product. The partners of this European Union project, however, are funded by their governments (Germany) and not by the company (Zoetis). Regarding the submitted data there are absolutely no competing interests with the company. The participation of PZ (Zoetis) does not alter the authors’ adherence to all the PLOS One policies.
Monocytes are immune cells linking innate and adaptive immunity and play an essential role as cells of the first line of defense against pathogens . Monocytes originate in the bone marrow and are released into the peripheral blood, where they circulate for several days before entering tissues to replenish tissue macrophage or dendritic cell populations . Recent studies have reported a consecutive migration of murine monocyte subsets: In response to tissue damage or infection, nonclassical monocytes (ncM) rapidly migrate out of the circulation and invade the damaged site. This early efflux of ncM is transient and rapidly followed by the recruitment of neutrophils and subsequently by classical monocytes (cM) . Monocytes are equipped with a large array of receptors that recognize various pathogens and mediate phagocytosis, and stimulated monocytes can produce large amounts of reactive oxygen species (ROS), chemokines and cytokines (e.g. chemokine (C-X-C motif) ligand 8 (CXCL8), CXCL1, interleukin (IL)-1β and tumor necrosis factor (TNF)-α) which are involved in the defense against pathogens , .
Studies in human and mice have shown that blood monocytes are a heterogeneous population and that monocyte subsets exert different functions. . Two subpopulations of human monocytes (CD14++CD16− and CD14+CD16+ monocytes) were initially defined based on the differential expression of the lipopolysaccharide (LPS) receptor CD14 and the FcγIIIR CD16 . Subsequent studies identified considerable heterogeneity within the CD16-positive monocyte population and allowed for discrimination between CD14++CD16+ and CD14+CD16++ subsets . Based on the new nomenclature, human monocytes are subdivided into three subsets on the basis of surface CD14 and CD16 expression. The major population of human monocytes (90%) with high CD14 but no CD16 expression (CD14++ CD16−) are now termed cM, whereas the minor population (10%) of human monocytes contain the intermediate monocytes (intM) subset, with low CD16 and high CD14 expression (CD14++ CD16+), and the ncM subset, with high CD16 and low CD14 expression (CD14+ CD16++) . In the murine system classical monocytes (cM) are defined as Ly6C++CD43+, intermediate monocytes (intM) as Ly6C++CD43++ and nonclassical monocytes (ncM) as Ly6C+CD43++ . Human cM have been shown to act as professional phagocytes, to generate ROS and to secrete cytokines in response to bacterial stimulation . Recently, human intM were considered as the monocytes subpopulation with the highest inflammatory potential, being the main producers of ROS  and inflammatory cytokines . Human and mouse ncM have been characterized as the monocyte subset which patrol and crawl along the endothelium in a leukocyte function-associated antigen (LFA)-1 dependent manner . NcM have further been shown to sense the presence of viruses and nucleic acids via toll-like receptor (TLR)-7 and TLR-8 . Some studies proposed that monocytes leave the bone marrow as classical cells, which can either directly invade inflamed tissues and differentiate into macrophages and/or dendritic cells, or they can differentiate into intermediate (CD14++CD16+) monocytes in the circulation , , .
Studies on bovine monocytes were so far restricted to the CD14-positive mononuclear cells (MNC) population , , , . Therefore, this study aimed at the definition of bovine blood monocyte subsets and the characterization of their phenotypical and functional heterogeneity.
Materials and Methods
This study was approved by the Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit (AZ 33.9-42502-05-09A/598). All procedures involving animals were carried out in accordance with German legislation on animal welfare.
Separation of Mononuclear Cells
Blood from healthy nonlactating, pluriparous German Holstein cows was obtained by venipuncture of the vena jugularis externa into heparinized vacutainer tubes (Becton Dickinson, Heidelberg, Germany). The blood was layered on Ficoll-Isopaque (PAA, Pasching, Austria) and centrifuged at 4°C for 30 min at 1000×g. The interphase containing MNC was washed 3 times (10 min, 4°C) in PBS (500×g, 250×g, 100×g) and finally suspended in culture medium.
Flow Cytometric Analysis of Monocyte Subsets
Surface marker expression on bovine monocyte subsets was determined using single and multiple labeling of bovine MNC (n = 6 animals) or MACS-separated monocyte subsets (n = 5 animals) using monoclonal antibodies to the molecules: CD16 (MCA5665F), CD14 (MCA1568PE), CD172a (MCA2041P647), MHC-II (MCA2226F), CD163 (MCA2311PE), CD4 (MCA1653A647), CD8 (MCA837A647), CD21 (MCA1424PE ) and CD335 (MCA2365PE) (all antibodies: AbD Serotec, Oxford, UK). Peripheral blood mononuclear cells (4×105) or MACS-separated monocyte subsets (1×105) from healthy animals were incubated with fluorochrome labeled monoclonal antibodies in PBS containing bovine serum albumin (5 g/L) and NaN3 (0.1 g/L). After 30 minutes in the dark (4C°), labeled cells were washed once and analyzed using the Accuri C6 flow cytometer (BD Biosciences). Dead cells were excluded from the analysis by adding propidium iodide (PI, 2 µg/ml, Calbiochem, Bad Soden, Germany). At least 100 000 total MNC or 20.000 monocytes were collected and analyzed with the CFlow Software, Version 1.0.264.15 (BD Biosciences).
Isolation of Bovine Monocyte Subsets
Bovine monocyte subsets were isolated using a tow-step (multiSort) MACS procedure according to their different CD14 and CD16 expression. After density gradient separation, mononuclear cells were labeled with a FITC-conjugated CD16-specific antibody (AbD Serotec, Oxford, UK) for 15 min and then with anti-FITC MultiSort MicroBeads (Anti-FITC MultiSort Kit; Miltenyi Biotec) to separate MNC into a CD16-positive fraction (containing intM and ncM) and a CD16-negative fraction (containing cM and other blood MNC). Bound beads to the CD16-positive fraction were released by incubation with MultiSort release reagent (included in the Anti-FITC MultiSort Kit) for 10 min. The CD16-negative and the CD16-positive the cell fractions were subsequently incubated with anti-CD14 MicroBeads (Miltenyi Biotec) and separated according to the manufacturer’s instructions: CD14-positive cells were positively selected from the CD16-negative fraction (cM) and from the CD16-positive fraction (intM). Flow through cells of the CD16-positive fraction incubated with anti-CD14 MicroBeads presented ncM. All steps of monocyte subset isolation were performed at 4°C. After each labeling step, the cells were washed with PBS-EDTA (300×g, 10 min). Negatively and positively selected cells were checked flow cytometrically for their viability and purity after labeling the cells with a PE-conjugated mouse anti bovine CD14 monoclonal antibody (ABD Serotec) and adding propidium iodide (2 µg/ml). This separation procedure yielded a purity of 94.9% ±5.4% for cM, 82.9% ±4.5% for intM and 90.3% ±2.2% for ncM. The mean viability was 92% ±5% for all subsets (n = 5 animals).
Generation of ROS
ROS generation was performed in 96-well round-bottom microtiter plates (Corning, NY, USA). Bovine MNC (3×105/well) in RPMI medium were incubated with heat killed and serum opsonized (45 min incubation with heat inactivated bovine serum; 37°C, 5% CO2 and subsequently washed with RPMI medium) Escherichia coli (E. coli) (50 bacteria/cell) or with 50 nmol/l PMA (Sigma, Germany) for 15 min (37°C, 5% CO2). For the detection of ROS, dihydrorhodamine (DHR 123, Mobitec, Goettingen, Germany) was added to the cells (750 ng/ml final). To identify monocyte subsets, combinations of fluorochrome-conjugated monoclonal antibodies to CD172a (MCA2041P647), CD14 (MCA1568A647) and MHC-II (MCA5655PE) were added to the cells. After incubation the cells were washed with RPMI medium and suspended in medium containing propidium iodide (PI, 2 µg/ml final, Calbiochem, Bad Soden, Germany) to exclude dead cells from the analysis. Using a combination of CD172a- and CD14-specific monoclonal antibodies, ncM were identified as CD172a-positive and CD14-negative. Using a combination of CD14- and MHC-II-specific monoclonal antibodies, intM and cM were identified as both CD14-positive and MHC-II-positive cells with a higher MHC-II expression (MHC-II++) on intM. The relative amount of generated ROS was determined by the median green fluorescence intensity of gated monocyte subsets after acquisition of 20 000 events (n = 5 animals).
Heat killed staphylococcus aureus (S. aureus) (Pansorbin, Calbiochem, Merck, Nottingham, UK) or E. coli (Institute of Microbiology, University of Veterinary Medicine, Hannover, Germany) were labeled with fluoresceinisothiocyanate (FITC, Sigma-Aldrich, St. Louis, Missouri, USA). FITC-conjugated and heat killed S. aureus or E. coli were opsonized with heterologous bovine serum (diluted 1∶10 with PBS) for 45 minutes at 37°C. Finally, bacteria were centrifuged at 14,000×g for 5 min and Pellet was suspended in RPMI medium and adjusted to 2×108 bacteria/mL after counting the bioparticles flow cytometrically. MACS-separated bovine monocyte subsets were plated in 48 well plates (1×105/well) and incubated for 24 h (37°C, 5% CO2) in RPMI medium. After this resting period, cells were incubated with opsonized bacteria (50 bacteria/cell) for 40 minutes (37°C, 5% CO2). Control samples were incubated without bacteria. After incubation, samples were flow cytometrically analyzed after addition of propidium iodide (PI, 2 µg/ml final) to exclude dead cells. Phagocytic activity of the three monocyte subsets was defined as the percentage of green fluorescing cells among viable cells (n = 4 animals).
In vitro Stimulation of Monocyte Subsets and RT-qPCR
MACS-separated monocyte subsets were suspended in RPMI medium (PAA, Pasching, Austria) supplemented with 10% (v/v) fetal calf serum and penicillin/streptomycin at 2×105 cells per ml. The cells were cultivated in 24 well plates (Costar, Cambridge, MA) at 2×105 cells per well for 24 h (37°C, 5% CO2). After this resting period, cells were stimulated for 3 h with LPS (1 µg/ml) (37°C, 5% CO2). Total RNA of the cells was extracted for quantitative real-time PCR analysis (see below) of selected cytokine and chemokine mRNA expression. RNA preparation and RT-qPCR has been described recently . In brief: Extraction of RNA was performed using the RNeasy Plus Micro Kit (Qiagen, Hilden, Germany) including the elimination of contaminating genomic DNA with a DNA eliminator column. Integrity and quality based on 18s- and 28s- units of RNA was checked by a microfluidic chip-based automated electrophoresis system (Experion Automated Electrophoresis System, Biorad, Munich, Germany). Experion RNA HighSense Chips were used according to the manufacturer’s instructions. With a total-RNA amount of 8 ng cDNA synthesis was performed using the Superscript++Reverse Transcriptase and oligo (dT) nucleotide primers (both Invitrogen, Karlsruhe, Germany) according to the manufacturer’s instructions. Subsequent RT-qPCR was conducted using the Power SYBR Green PCR Master Mix (Applied Biosystems, Darmstadt, Germany). Primers for the analyzed genes are listed in Table 1. Thermocycling was performed in a StepOnePlus Real Time PCR system (Applied Biosystems, Darmstadt, Germany). The quality of amplification was verified by melt curve analysis. A dilution series (106–102 copies) of cDNA subclones was analyzed for each gene simultaneously with the samples and used for the determination of the relative copy numbers of individual transcripts. The amplification efficiency was calculated from the slope of the standard curve by the formula: E = 10−1/slope for each run and ranged between 90% and 110% (Cells from 3 different animals, samples were tested in duplicates in the RT-PCR).
In vitro Stimulation of IL-1β Secretion
MACS-separated monocyte subsets (n = 5 animals) were suspended in IMDM medium (PAA, Pasching, Austria) supplemented with 10% (v/v) fetal calf serum and penicillin/streptomycin at 1×105 cells per ml. The cells were cultivated in 24 well plates (Costar, Cambridge, MA) at 1×105 cells per well for 24 h (37°C, 5% CO2). After this resting period, cells were incubated with either culture medium (IMDM, negative control) or LPS (1 µg/mL, Sigma-Aldrich, Germany) for 4 h (37°C, 5% CO2). Adenosine triphosphate (ATP) (5 mmol/L) was added to the culture for an additional hour. After a total of 5 hours in vitro, cell culture supernatants were collected and stored at −70°C until assayed .
Flat-bottomed 96-well plates (MaxiSorp; Nunc, Roskilde, Denmark) were coated with monoclonal anti-ovine IL-1β (AbD Serotec, 100 µL/well, 4 µg/mL) in carbonate-bicarbonate buffer (15 mmol/l Na2CO3, 35 mmol/l NaHCO3, pH 9.6) and incubated for 18 h at 4°C. Plates were washed five times with phosphate buffer (2.5 mmol/l NaH2PO4, 7.5 mmol/l Na2HPO4, 145 mmol/l NaCl, 0.1% (v/v) Tween 20, pH 7.2). Each well was filled with 75 µl of sample and plates were incubated on a rotating platform for 1 hour at RT. Serial dilutions of purified bovine recombinant IL-1β (AbD Serotec) were included in each assay to construct a standard curve. Samples and recombinant IL-1β were tested in duplicates. Plates were washed five times with phosphate buffer and wells were filled with 75 µl of rabbit anti-bovine IL-1β polyclonal antibody (AbD Serotec, 2 µg/mL). Plates were incubated for 1 h at room temperature, washed, and peroxidase-conjugated AffiniPure goat anti rabbit IgG (FC) (Dianova) was added. After 1 h at RT the plates were washed and subsequently filled with 75 µl/well peroxidase substrate buffer (33.3 mmol/l citric acid, 66.7 mmol/l NaH2PO4, pH 5.0) supplemented with 130 µg/mL 3,3′,5,5′-tetramethylbenzidine (TMB, Sigma, Germany) and 0.01% (v/v) H2O2 (all chemicals from Sigma-Aldrich, Germany). After 20 min at RT in the dark adding 75 µl of 0.5 M H2SO4 to each well stopped the reaction. Optical densities were read in an ELISA microplate reader (MR 5000, Dynatech, Denkendorf, Germany) at 450 nm and 630 nm. Bovine IL-1β concentrations were calculated by referring to a standard curve. The detection limit of the assay was 100 pg/mL.
Whole Blood Stimulation
Blood from healthy cattle (n = 7 animals) was incubated with recombinant bovine interferon (IFN)γ (10 ng/ml), IL-4 and IL-13 (5 ng/ml of each), CCL-5 (50 nmol/l), TNF-α (10 ng/ml) or IL-1β (10 ng/ml) for 4 h (37°C, 5% CO2). After incubation the blood was diluted with phosphate buffer saline (1∶1) and centrifuged at 4°C for 10 min at 1000×g and the supernatant fluid was expelled. Twice hypotonic lysis of erythrocytes was done by adding distilled water (20 ml for 20 sec.) followed by the addition of 20 ml double concentrated PBS. Finally the cells were suspended in PBS and stained with monoclonal antibodies to CD16 (MCA5665F), CD14 (MCA1568PE) and CD172a (MCA2041P647) (see above).
Statistical analysis was carried out using the software Prism (GraphPad software). Results are expressed as means ± S.E. of the mean (SEM). Differences between means were tested with one-factorial analysis of variance (ANOVA) and Bonferroni’s correction for normally distributed data. Results were considered statistically significant at a p-value of less than 0.05.
Phenotypic Characterization of Bovine Monocyte Subsets
Bovine monocytes were identified based on CD172a expression. CD172a-positive cells were negative for the T cell marker CD4 and CD8, the B cell marker CD21, the NK cell marker NKp46 (CD335), and the γδ T cell marker WC1 (Fig. 1B). Based on the cell surface expression of CD14 and CD16, three blood monocyte subsets could be defined after flow cytometry (Fig. 1A, Table 2). The major subpopulation of bovine monocytes (cM) showed high expression of CD14 and no expression of CD16 (CD14+/CD16−). A second subset of monocytes (intM) expressed highly CD14 and displayed low expression of CD16 (CD14+/CD16+). A third monocyte subset was defined by high expression of CD16 and no expression of CD14 (CD14−/CD16+). After magnetic-activated cell sorting of three monocyte subsets (Fig. 2A), acridine orange stained nuclei appeared to be generally reniform. NcM appeared to be slightly smaller (Fig. 2B) which was proven by flow cytometry: ncM displayed significantly lower FSC (p<0.001) and SSC (p<0.05) values compared to classical and intermediate monocytes (Fig. 2C). Monocyte subsets differed significantly in their expression of CD163, CD172a, and MHC class II molecules. The expression level of CD172a was higher on intM and ncM, whereas the CD163 was expressed highest on cM. IntM showed the highest MHC class II expression (Fig. 3). Sorted monocyte subsets were negative for the T cell marker CD4 and CD8, the B cell marker CD21, the NK cell marker NKp46 (CD335), or WC1 (a marker of a subset of γδ T cells) (Data not shown).
(A) Three-color immunofluorescence of bovine MNC with mAbs to CD172a, CD14 and CD16 defines three monocyte subsets in peripheral blood. Viable (propidium-iodide-negative) mononuclear cells, based on forward and side scatter characteristics, were gated on CD172a-positive cells. Dot plots of CD14 and CD16 expression display classical monocytes (CD14+CD16−, upper left), intermediate monocytes (CD14+CD16+, upper right) and nonclassical monocytes (CD14-CD16+, lower right). (B) Monocytes were gated in a side scatter/CD172a dot plot, identifying monocytes as CD172a-positive cells. Histograms show that CD172a-positive cells do not express common markers of B cell (CD21), T cell (CD2, CD4 or CD8), NK cell (NKp46) or blood γδ T cell (WC1). Data are shown for cells from one of five tested animals.
(A) Bovine cM (CD14+ CD16−), intM (CD14+ CD16+) and ncM (CD14− CD16+) subsets were separated from bovine MNC using a two-step MACS procedure as described in material and methods. Separated subsets were labeled with monoclonal antibodies to CD14 and CD16 to identify their purity. Representative examples from 5 independent experiments are shown. (B) Microscopic images of separated monocyte subsets are shown with magnification 100 after staining with acridine orange. (C) Bovine MNC were labeled with monoclonal antibodies to CD14 and CD16 to identify three monocyte subsets. Gated monocyte subsets were presented in FSC against SSC. The median of FSC and SSC of the individual subsets was measured (n = 6 cows) and presented as mean ± SEM. Statistical analysis of significance were performed using ANOVA and Bonferroni’s correction for normally distributed data. *(P<0,01).
MACS-separated monocyte subsets (n = 5 cows) were labeled with antibodies to different monocyte markers or isotype controls. After dead cell exclusion with propidium iodide, data were measured as median fluorescence intensity (MFI) and presented as means ± SEM. Background fluorescence (measured in negative controls) was subtracted. Statistical analysis of significance was performed using ANOVA and Bonferroni’s correction for normally distributed data *(P<0,01).
Monocyte Subsets Differ in their Capacity to Phagocytize and to Generate Reactive Oxygen Species
To see whether monocyte subsets show differences in their antimicrobial functions, we analyzed the ability of the three subsets to phagocytize bacteria and to produce ROS. CM significantly phagocytized more serum-opsonized bacteria compared to intM and ncM (Fig. 4A). No significant difference between the capacity to phagocytize S. aureus or E. coli bacteria was observed. Whereas the low phagocytosis capacity of ncM corresponded to the nearly absent ability to generate ROS (Fig. 4B), intermediate monocytes displayed the highest ROS generation capacity. Whether ROS generation was induced by PMA or fixed E. coli bacteria had no influence on the monocyte subset capacity (intM>cM>ncM).
(A) MACS-separated cM, intM and ncM subsets (1×105/well) were incubated with heat killed FITC-labeled S. aureus or E. coli, which have been opsonized with bovine serum for 45 minutes. Control cells were incubated only in medium. The percentage of FITC-positive cells within viable (PI-negative) cells were determined flow cytometrically for the three monocyte subsets and are denoted as mean value ± SEM (n = 3 animals). (B) Flow cytometric analysis of ROS-formation by bovine monocyte subsets. Bovine MNC (n = 4 animals) were stimulated with PMA or heat killed and serum opsonized E. coli in the presence of DHR-123. The ncM subset was identified after labeling the cells with antibodies to CD172a and CD14 as CD172a positive and CD14 low cells. In a combination of CD14 and MHC-II monoclonal antibodies, the intM and cM subsets could be identified as both CD14 high cells with higher MHC-II expression on the intM subset. Cells were gated on viable (propidium-iodide-negative) CD172a-positive cells or CD14 high cells. ROS generation was calculated as the median green fluorescence intensity of gated monocyte subsets after subtracting the MFI of non-stimulated cells and presented as mean ± SEM. Differences between groups were calculated using the one-way ANOVA and were considered significant (*) if p<0.05.
Cytokine and Chemokine Expression Pattern in Bovine Monocyte Subsets
To see whether the monocyte subsets are biased in their stimulated gene expression, we analyzed genes, which cover a spectrum of pro-inflammatory (IL1B, TNF, iNOS) and anti-inflammatory (ARG1) cytokines. Since monocytes are among the cells attracting neutrophils, two chemokines were analyzed which bind differentially to CXCR1 and/or CXCR2 on neutrophils. This would help us to understand the role of these subsets in the chemotaxis and functional modulation of neutrophils. IntM and ncM, displayed a homogenous baseline expression of the analysed genes, whereas cM showed up with highly variable baseline expression (Fig 5). Differences in baseline expression showed no statistical significance between the three monocyte subsets. For all analysed genes, LPS stimulation did not induce a significant upregulation in cM or ncM. In intM, LPS stimulation induced a significant (p<0.05) upregulation of CXCL8, CXCL1, IL1B, and TNF.
Bovine MACS-separated cM, intM and ncM (n = 3 animals) were stimulated with LPS (1 µg/ml) for 3 h. Messenger RNA copy numbers of the chemokines CXCL1 and CXCL8 and the cytokines IL-1β, Arginase1, iNOS and TNF-α were determined in 8 ng total RNA by quantitative RT-PCR. Samples were tested in duplicates. Differences between treatments and between groups (one-way ANOVA) were considered significant (*) at p<0.05.
Among LPS-stimulated monocyte subsets, ncM showed significantly lower expression of CXCL8, CXCL1 and IL-1β compared to cM and intM, and a lower expression of Arginase I compared to cM (p<0.05).
Inflammasome Activation in Bovine Monocyte Subsets
The secretion of the pro-inflammatory cytokine IL-1β requires two stimulating signals that activate the inflammasome. ATP has been shown to act as a second signal for the assembly of the NLRP3 inflammasome in LPS-primed bovine monocytes leading to the secretion of IL-1β . IL-1β was determined in supernatants of LPS-primed/ATP-stimulated bovine monocyte subsets. The combined LPS/ATP stimulation of cM and intM resulted in a significant (12–13 fold) IL-1β increase versus stimulation with LPS as a single stimulus (Fig. 6). Supernatants of ncM, irrespective of activation, contained nearly no detectable IL-1β. Only the ncM of one animal showed a minimal secretion after treatment with LPS/ATP. Supernatant of intM stimulated with the combination of LPS/ATP contained significantly more IL-1β than those of LPS/ATP-stimulated cM.
Analysis of inflammasome activation was done by measuring the secreted IL-1β in medium supernatants of monocyte subsets after combined stimulation with LPS and ATP. MACS-separated bovine monocyte subsets (n = 5 animals) were primed for 5 h with LPS (1 µg/mL) and 5 mmol/L ATP was added to the culture for an additional hour. IL-1β in cell supernatants was measured by ELISA. Differences between groups (one-way ANOVA) were considered significant (*) at p<0.05.
IFNγ Increases the Expression of CD16 on cM Monocytes
To test the hypothesis that a developmental relationship exists between monocyte subsets, whole blood was stimulated with inflammatory (IFNγ, IL-1β, TNF-α) and anti-inflammatory cytokines (IL-4, IL-13) as well as a monocyte attracting chemokine (CCL5). The stimulation with IFNγ selectively induced an upregulated expression of CD16 on classical monocytes (Fig. 7A). This shift significantly increased the percentage of intM among all monocytes and reduced the fraction of cM (Fig. 7B).
Whole blood samples (n = 7 animals) were incubated with the cytokines IFNγ, IL-4/IL-13, TNF-α or IL-1β or the chemokine CCL5 for 4 h. Leukocytes were stained with monoclonal antibodies to CD172a, CD14 and CD16. After gating on vital (PI-negative) MNC, agate was made on CD172a-positive cells. CD172a-positive cells were presented in CD14 and CD16 dot plot. Mean fluorescence intensity of CD16 (A) and the percentage (B) of the three monocyte subsets was calculated and presented as mean ± SEM. Differences between groups were calculated using the one-way ANOVA and were considered significant (*) if p<0.05.
Studies in mice and human have shown that peripheral blood monocytes represent a heterogeneous population of circulating cells with differences in size, granularity, phenotype and function . Since no data were available for bovine monocytes, this study aimed at the characterization of bovine peripheral blood monocyte heterogeneity.
Since bovine monocytes are usually described as CD14-positive , , , and one of the human monocyte subpopulations express very little or no CD14, we first identified a marker expressed on all putative bovine monocytes. An antibody specific for the Colony-Stimulating Factor-1 receptor (CD115) which is used to detect human and murine monocytes  was not available for bovine monocytes. Double staining of MNC with anti-CD172a, also known as signal-regulatory protein alpha (SIRPalpha), and antibodies specific for Nkp-46, CD2, CD4, CD8 or CD21 proved, that CD172a-positive cells among MNC are distinct from NK cells, T cells, and B cells. SIRPs have been shown to be expressed at high levels in human myeloid cells, including macrophages, monocytes, granulocytes and DC . CD172a has been identified as pan monocyte marker of porcine monocytes , . CD172a is also expressed at low levels on bovine  and porcine  plasmacytoid DC. Although not formally proven, CD172a-positive bovine monocyte subsets (defined by CD172a, CD14 and CD16 staining) are also distinct from blood dendritic cells, since they are negative for both CD14 and CD16 . Thus, the use of CD172a as a marker to detect all monocytes in bovine peripheral blood is far superior over the use of CD14.
The recently updated classification of human monocyte heterogeneity identifies three human monocyte subsets, based on the differential expression of CD14 and CD16 . This could also be shown for bovine monocytes after triple staining with antibodies specific for CD172a, CD14, and CD16. As in human blood , bovine cM constituted the majority (89.1%) of bovine peripheral blood monocytes. Relative expression densities of CD14, CD16, MHC-II and CD163 on bovine and human monocyte subsets also suggests a similar phenotype of monocyte subsets in both species . This is also the case for the size of bovine and human ncM, being smaller and less granular compared to cM and intM . Thus, regarding phenotype and frequency in blood, bovine monocytes appear to share many homologies with their human counterparts.
We next asked, whether the similarities also extend to the functionality of the monocyte subsets. We found the highest phagocytic capacity in bovine cM, which is in line with previously published data to the human cM subset , . Bovine intM produced the highest amount of ROS and showed enhanced levels of inflammatory cytokines (TNF-α, IL-1β). This is comparable with newer studies describing human intM as main producers of ROS and pro-inflammatory cytokines , . Overall, inflammatory responses, including phagocytosis, ROS generation and cytokine production in response to bacterial stimulation, appeared to be mediated by the two bovine CD14-positive monocyte subsets (cM, intM).
This is only partially overlapping with the human system, where the combined human CD16-positive subset (including intM and ncM) was generally termed ‘pro-inflammatory monocytes’ , . Human CD16-positive monocytes produced high amounts of pro-inflammatory cytokines ,  with human ncM producing the highest amount of IL-1β in response to LPS stimulation . ROS generation of human ncM was equivalent to that of cM and intM .
In contrast, bovine ncM were nearly unable to respond to LPS/ATP stimulation with a detectable secretion of IL-1β. Moreover, they displayed the lowest phagocytic capacity of all bovine monocyte subsets, showed virtually no ROS generation and expressed lowest copy numbers of transcripts for all tested genes. Murine and human ncM ,  crawl on endothelial cells and rapidly migrate into tissues in response to infection or tissue damage. This early efflux of ncM seems to be relevant for the subsequent recruitment of neutrophils . The low mRNA expression of neutrophil-attracting chemokines in bovine ncM, which could not be stimulated by LPS, suggests a marginal role of these cells in the recruitment of neutrophils to the infected tissue. The possible function of bovine ncM in vivo is obscure.
Some studies proposed that intM are transitional cells bridging between cM and ncM, suggesting a developmental relationship between the monocyte subsets , , . This may indeed be the case with bovine cells, since incubation of whole blood with INFγ induced an upregulated CD16 expression on cM causing an increased fraction of intM. This is in part supported by an earlier study in humans where the combined treatment of patients with M-CSF and IFNγ resulted in more CD16 expression on cM and the expansion of CD16-positive monocytes . In our study we found no indications that IFNγ induces the differentiation of intM into ncM.
Cell-surface expression of CD14 and CD16 among CD172a-positive cells define three functionally and phenotypically subsets of bovine monocytes resembling the human classical (CD14+CD16−), intermediate (CD14+CD16+), and nonclassical (CD14+CD16+) monocytes. Phenotypic and functional characteristics indicate similarities between bovine and human cM and intM, whereas significant functional differences exist between bovine and human ncM.
Conceived and designed the experiments: HJS JH IMS. Performed the experiments: JH AD. Analyzed the data: JH AD HJS. Wrote the paper: JH AD HJS. Revision: OS DS IMS PZ HJS. Final approval: HJS IMS DS PZ OS.
- 1. Hume DA, Ross IL, Himes SR, Sasmono RT, Wells CA, et al. (2002) The mononuclear phagocyte system revisited. J Leukoc Biol 72: 621–627.
- 2. Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27: 669–692.
- 3. Soehnlein O, Lindbom L (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol 10: 427–439.
- 4. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, et al. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666–670.
- 5. Ziegler-Heitbrock HW (2000) Definition of human blood monocytes. J Leukoc Biol 67: 603–606.
- 6. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953–964.
- 7. Passlick B, Flieger D, Ziegler-Heitbrock HW (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527–2534.
- 8. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, et al. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197: 1701–1707.
- 9. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74–80.
- 10. Zawada AM, Rogacev KS, Schirmer SH, Sester M, Bohm M, et al.. (2012) Monocyte heterogeneity in human cardiovascular disease. Immunobiology.
- 11. Zawada AM, Rogacev KS, Rotter B, Winter P, Marell RR, et al. (2011) SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118: e50–61.
- 12. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, et al. (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33: 375–386.
- 13. Heine GH, Ortiz A, Massy ZA, Lindholm B, Wiecek A, et al.. (2012) Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol.
- 14. Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, et al. (1994) Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 54: 4084–4090.
- 15. Machugh DE, Taraktsoglou M, Killick KE, Nalpas NC, Browne JA, et al. (2012) Pan-genomic analysis of bovine monocyte-derived macrophage gene expression in response to in vitro infection with Mycobacterium avium subspecies paratuberculosis. Vet Res 43: 25.
- 16. Magil AB, Tinckam KJ (2006) Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant 21: 1382–1388.
- 17. Taraktsoglou M, Szalabska U, Magee DA, Browne JA, Sweeney T, et al. (2011) Transcriptional profiling of immune genes in bovine monocyte-derived macrophages exposed to bacterial antigens. Vet Immunol Immunopathol 140: 130–139.
- 18. Magee DA, Taraktsoglou M, Killick KE, Nalpas NC, Browne JA, et al. (2012) Global gene expression and systems biology analysis of bovine monocyte-derived macrophages in response to in vitro challenge with Mycobacterium bovis. PLoS One 7: e32034.
- 19. Duvel A, Frank C, Schnapper A, Schuberth HJ, Sipka A Classically or alternatively activated bovine monocyte-derived macrophages in vitro do not resemble CD163/Calprotectin biased macrophage populations in the teat. Innate Immun.
- 20. Hussen J, Duvel A, Koy M, Schuberth HJ (2012) Inflammasome activation in bovine monocytes by extracellular ATP does not require the purinergic receptor P2X7. Dev Comp Immunol 38: 312–320.
- 21. van Beek EM, Cochrane F, Barclay AN, van den Berg TK (2005) Signal regulatory proteins in the immune system. J Immunol 175: 7781–7787.
- 22. Moreno S, Alvarez B, Poderoso T, Revilla C, Ezquerra A, et al. (2010) Porcine monocyte subsets differ in the expression of CCR2 and in their responsiveness to CCL2. Vet Res 41: 76.
- 23. Chamorro S, Revilla C, Alvarez B, Alonso F, Ezquerra A, et al. (2005) Phenotypic and functional heterogeneity of porcine blood monocytes and its relation with maturation. Immunology 114: 63–71.
- 24. Gibson A, Miah S, Griebel P, Brownlie J, Werling D (2012) Identification of a lineage negative cell population in bovine peripheral blood with the ability to mount a strong type I interferon response. Dev Comp Immunol 36: 332–341.
- 25. Summerfield A, Guzylack-Piriou L, Schaub A, Carrasco CP, Tache V, et al. (2003) Porcine peripheral blood dendritic cells and natural interferon-producing cells. Immunology 110: 440–449.
- 26. Frankenberger M, Ekici AB, Angstwurm MW, Hoffmann H, Hofer TP, et al.. (2012) A defect of CD16-positive monocytes can occur without disease. Immunobiology.
- 27. Wong KL, Tai JJ, Wong WC, Han H, Sem X, et al. (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118: e16–31.
- 28. Rogacev KS, Heine GH (2010) Human monocyte heterogeneity–a nephrological perspective. Nephrol Ther 6: 219–225.
- 29. Ziegler-Heitbrock L (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81: 584–592.
- 30. Frankenberger M, Sternsdorf T, Pechumer H, Pforte A, Ziegler-Heitbrock HW (1996) Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 87: 373–377.
- 31. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, et al. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 168: 3536–3542.
- 32. Neuvians TP, Schams D, Berisha B, Pfaffl MW (2004) Involvement of pro-inflammatory cytokines, mediators of inflammation, and basic fibroblast growth factor in prostaglandin F2alpha-induced luteolysis in bovine corpus luteum. Biol Reprod 70: 473–480.
- 33. Yang W, Zerbe H, Petzl W, Brunner RM, Gunther J, et al. (2008) Bovine TLR2 and TLR4 properly transduce signals from Staphylococcus aureus and E. coli, but S. aureus fails to both activate NF-kappaB in mammary epithelial cells and to quickly induce TNFalpha and interleukin-8 (CXCL8) expression in the udder. Mol Immunol 45: 1385–1397.
- 34. Taubert A, Hermosilla C (2008) Bovine recombinant IFNgamma induces endothelial cell gene transcription of immunoregulatory molecules and upregulates PMN and PBMC adhesion on bovine endothelial cells. Vet Res Commun 32: 35–47.
- 35. Mirkovitch J, Konig A, Sauter KS, Brcic M, Hope JC, et al. (2006) Single-cell analysis divides bovine monocyte-derived dendritic cells into subsets expressing either high or low levels of inducible nitric oxide synthase. Vet Immunol Immunopathol 114: 1–14.